DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Sallah S, Gagnon GA.
Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel.
Cancer Invest 2000;
18 (03) 191-196
We do not assume any responsibility for the contents of the web pages of other providers.